Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:02 AM
Ignite Modification Date:
2025-12-25 @ 12:02 AM
NCT ID:
NCT07217158
Eligibility Criteria:
Inclusion Criteria:
* Male and female subjects 15 - 70 years of age
* Previous diagnosis of ADPKD (based on Ravine et al. criteria)
* Class 1 A-E according to imaging classification
* estimated GFR\> 45 mL/min/1.73 m2 (CKD-EPI)
* Ability to provide written, informed consent
Exclusion Criteria:
* Class 2, according to imaging classification
* A concomitant systemic disease affecting the kidney
* Diabetes mellitus
* Predicted urine protein excretion in \>1 g/24 hrs. and or abnormal urinalysis
* Use of antioxidants, i.e., vitamins, Nrf2 activators
* Patients who are part of an interventional study or taking tolvaptan
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Maximum Age:
70 Years
Study:
NCT07217158
Study Brief:
Protocol Section:
NCT07217158